Ads
related to: car t-cell therapy
Search results
Advances in CAR T-Cell Therapy for Multiple Myeloma
MedPage Today· 6 days agoB-cell maturation antigen (BCMA)-directed CAR T-cell therapies are now established options for treating multiple myeloma after relapse ...
Understanding CAR T-cell therapy: A conversation with Northside’s Dr. Melhem Solh - Atlanta Business...
The Business Journals· 3 days agoDr. Melhem Solh, medical director of the cellular therapy program at Northside Hospital, answers...
Health Beat: Do the benefits of CAR T-Cell therapy outweigh the risks?
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoIn 2017, the FDA approved the first CAR T-cell therapy. Medical experts call it a "breakthrough" and...
Carl June compares his new CAR T-cell therapy to 'an armored truck or tank' - Philadelphia Business...
The Business Journals· 3 days agoUniversity of Pennsylvania researchers presented phase 1 clinical trial of a new "armored" form of ...
CAR T-Cell Therapy Could Be A Gamechanger For Autoimmune Diseases
Forbes· 7 days agoA recent study in the New England Journal of Medicine grabbed the attention of the medical community...
Get Full Control Of Your T Cell Isolation For Your CAR T Cell Therapy Manufacturing
BioresearchOnline· 2 days agoCell therapies offer promising avenues for potentially treating malignancies that are currently...
Response To FDA Black Box Warning
BioresearchOnline· 3 days agoThe FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies, which involve genetically ...
New 'armored' CAR produces responses in patients whose cancers don't respond to current CAR T cell...
Medical Xpress· 4 days agoA new "armored" form of CAR T cell therapy, developed by Carl June, MD, the Richard W. Vague Professor in Immunotherapy ...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Zacks via Yahoo Finance· 22 hours agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
...Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory...
Morningstar· 7 days agoU.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed ...